Cargando…
Immunotherapy in the management of melanoma: current status
As the rate of melanoma continues to increase, so does the need for more effective and durable therapies. Despite considerable research, the management of advanced disease remains challenging. Numerous therapies are being investigated, many of which aim at upregulating the immune system’s innate abi...
Autores principales: | Alston, Dylan, Brewer, Jerry D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928361/ https://www.ncbi.nlm.nih.gov/pubmed/27471683 http://dx.doi.org/10.2147/ITT.S30824 |
Ejemplares similares
-
Current status and perspectives in immunotherapy for metastatic
melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018) -
Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
por: Anko, Mayuka, et al.
Publicado: (2021) -
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
por: Kaufman, Howard L, et al.
Publicado: (2014) -
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives
por: Middleton, Mark R., et al.
Publicado: (2020) -
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)